1. Home
  2. ELMD vs GNFT Comparison

ELMD vs GNFT Comparison

Compare ELMD & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELMD
  • GNFT
  • Stock Information
  • Founded
  • ELMD 1992
  • GNFT 1999
  • Country
  • ELMD United States
  • GNFT France
  • Employees
  • ELMD N/A
  • GNFT N/A
  • Industry
  • ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ELMD Health Care
  • GNFT Health Care
  • Exchange
  • ELMD Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • ELMD 206.5M
  • GNFT 186.3M
  • IPO Year
  • ELMD 2010
  • GNFT 2019
  • Fundamental
  • Price
  • ELMD $24.86
  • GNFT $3.92
  • Analyst Decision
  • ELMD Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • ELMD 2
  • GNFT 2
  • Target Price
  • ELMD $35.50
  • GNFT $11.00
  • AVG Volume (30 Days)
  • ELMD 77.2K
  • GNFT 3.9K
  • Earning Date
  • ELMD 08-26-2025
  • GNFT 09-22-2025
  • Dividend Yield
  • ELMD N/A
  • GNFT N/A
  • EPS Growth
  • ELMD 46.55
  • GNFT N/A
  • EPS
  • ELMD 0.85
  • GNFT 0.03
  • Revenue
  • ELMD $64,000,000.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • ELMD $11.25
  • GNFT $5.15
  • Revenue Next Year
  • ELMD $8.82
  • GNFT N/A
  • P/E Ratio
  • ELMD $29.02
  • GNFT $129.22
  • Revenue Growth
  • ELMD 16.97
  • GNFT 105.01
  • 52 Week Low
  • ELMD $16.58
  • GNFT $2.55
  • 52 Week High
  • ELMD $35.56
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • ELMD 70.37
  • GNFT 46.69
  • Support Level
  • ELMD $23.61
  • GNFT $3.85
  • Resistance Level
  • ELMD $25.15
  • GNFT $4.16
  • Average True Range (ATR)
  • ELMD 1.00
  • GNFT 0.13
  • MACD
  • ELMD 0.40
  • GNFT -0.04
  • Stochastic Oscillator
  • ELMD 92.74
  • GNFT 9.95

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: